Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FB301 for Vaginal Dysbiosis in Women Undergoing Frozen Embryo Transfer
NCT07453069Phase 2Recruiting
- Sponsor
- Freya Biosciences
- Start
- Jul 2026
- Primary completion
- Oct 2026
- Modality
- Prophylactic Vaccines, Microbiome Therapeutics, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of FB-301 in Vaginal dysbiosis, sponsored by Freya Biosciences. Started Jul 2026; status: recruiting.
02
Drugs
FB-301
03
Conditions
Vaginal dysbiosis
Beyond the preview
Go deeper on NCT07453069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07453069.